The numbers As of July 31, 2025, the FDA had received a combined 1,150 adverse event reports related to compounded versions of semaglutide and tirzepatide
Superpower does not offer this substance
Patients managing weight, energy balance, or metabolic conditions benefit significantly from a structured NAD+ program
Lipotropic Injections at Defy Medical Defy Medical offers access to Lipo-C injections as a fat loss and weight management aid (as appropriate)
The next era of weight health isnt about access to medication alone, its about helping people succeed on it, said Tara Comonte, CEO of Weight Watchers
Larger peptides with post-translational modifications (like the fatty diacid moiety on retatrutide) are more susceptible to degradation than simpler sequences